Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
Sep 19, 16:00
Mithra Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 19, 2024 | 607.54M |
| September 18, 2024 | 607.54M |
| September 17, 2024 | 607.54M |
| September 16, 2024 | 607.54M |
| September 13, 2024 | 607.54M |
| September 12, 2024 | 607.54M |
| September 11, 2024 | 607.54M |
| September 10, 2024 | 607.54M |
| September 09, 2024 | 607.54M |
| September 06, 2024 | 607.54M |
| September 05, 2024 | 607.54M |
| September 04, 2024 | 607.54M |
| September 03, 2024 | 607.54M |
| August 30, 2024 | 607.54M |
| August 29, 2024 | 607.54M |
| August 28, 2024 | 607.54M |
| August 27, 2024 | 607.54M |
| August 26, 2024 | 607.54M |
| August 23, 2024 | 607.54M |
| August 22, 2024 | 607.54M |
| August 21, 2024 | 607.54M |
| August 20, 2024 | 607.54M |
| August 19, 2024 | 607.54M |
| August 16, 2024 | 607.54M |
| August 15, 2024 | 607.54M |
| Date | Value |
|---|---|
| August 14, 2024 | 607.54M |
| August 13, 2024 | 607.54M |
| August 12, 2024 | 607.54M |
| August 09, 2024 | 607.54M |
| August 08, 2024 | 607.54M |
| August 07, 2024 | 607.54M |
| August 06, 2024 | 607.54M |
| August 05, 2024 | 607.54M |
| August 02, 2024 | 607.54M |
| August 01, 2024 | 607.54M |
| July 31, 2024 | 607.54M |
| July 30, 2024 | 607.54M |
| July 29, 2024 | 607.54M |
| July 26, 2024 | 607.54M |
| July 25, 2024 | 607.54M |
| July 24, 2024 | 607.54M |
| July 23, 2024 | 607.54M |
| July 22, 2024 | 607.54M |
| July 19, 2024 | 607.54M |
| July 18, 2024 | 607.54M |
| July 17, 2024 | 607.54M |
| July 16, 2024 | 607.54M |
| July 15, 2024 | 607.54M |
| July 12, 2024 | 607.54M |
| July 11, 2024 | 607.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
507.88M
Minimum
Sep 07 2022
1.157B
Maximum
Feb 01 2022
655.46M
Average
607.54M
Median
Sep 18 2023
Enterprise Value Benchmarks
| Galapagos NV | -1.671B |
| UCB SA | 36.24B |
| Nyxoah SA | 222.43M |
| Celyad Oncology SA | -- |
| MDxHealth SA | 102.52M |